Scynexis SCYX
NASDAQ SCYX
$5.23 +0.08 (+1.62%)
At close: Aug 20, 2026 · 2:54 PM UTC

Scynexis (SCYX) Total Debt Growth (3y) (2016 - 2021)

Scynexis (SCYX) Total Debt Growth (3y) (2016 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Haleon 43.86 Bn 42.90 Bn - 15.43%
2 Teva Pharmaceutical Industries 43.19 Bn 39.54 Bn 2.15 Bn -7.08%
3 Zoetis 31.46 Bn 29.79 Bn 1.05 Bn 11.33%
4 Takeda Pharmaceutical 28.57 Bn 22.77 Bn 5.10 Bn -3.67%
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -10.43%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn -
8 Elanco Animal Health 11.71 Bn 11.18 Bn 798.00 Mn -13.72%
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - 92.83%
10 Scynexis 61.87 Mn -52.82 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 23.98%
Sep 30, 2021 24.06%
Jun 30, 2021 24.05%
Mar 31, 2017 -1.46%
Dec 31, 2016 -1.69%